The University of Liverpool Patent applications |
Patent application number | Title | Published |
20150299380 | SOLUBLE POLYMERS - Polymers exhibiting solubility, conjugation and microporosity are processable and useful for a variety of applications. The polymers comprise repeating units which are linked together to form rigid macromolecular structures which do not exhibit space-efficient packing. The polymers may comprise aromatic structures, e.g. fused aromatic structures and/or multiply bonded aromatic structures, and may comprise solubilising groups such as for example branched alkyl groups or siliyl groups. | 10-22-2015 |
20150272984 | AGENTS FOR THE PREVENTION AND/OR TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE - The present invention relates to the use of agents (including heparin derivatives) for the prevention and/or treatment of CNS damage. | 10-01-2015 |
20150258735 | LASER-PRODUCED POROUS SURFACE - The present invention disclosed a method of producing a three-dimensional porous tissue in-growth structure. The method includes the steps of depositing a first layer of metal powder and scanning the first layer of metal powder with a laser beam to form a portion of a plurality of predetermined unit cells. Depositing at least one additional layer of metal powder onto a previous layer and repeating the step of scanning a laser beam for at least one of the additional layers in order to continuing forming the predetermined unit cells. The method further includes continuing the depositing and scanning steps to form a medical implant. | 09-17-2015 |
20140249643 | LASER-PRODUCED POROUS SURFACE - A method of forming an implant having a porous tissue ingrowth structure and a bearing support structure. The method includes depositing a first layer of a metal powder onto a substrate, scanning a laser beam over the powder so as to sinter the metal powder at predetermined locations, depositing at least one layer of the metal powder onto the first layer and repeating the scanning of the laser beam. | 09-04-2014 |
20140249239 | Microporous Polymers, Methods for the Preparation Thereof, and Uses Thereof - A method for preparing a conjugated microporous polymer comprises the coupling of an alkynyl aryl monomer having a plurality of terminal alkyne groups with an iodo- or bromo-aryl monomer having a plurality of halogen atoms in the presence of a palladium (0) catalyst. The conjugated microporous polymer comprises nodes comprising at least one aryl unit and struts comprising at least one alkyne unit and at least one aryl unit, wherein a node is bonded from its aryl unit or units to at least two struts via alkyne units. Such polymers are useful in numerous areas such as separations, controlled release, gas storage and supports for catalysts. | 09-04-2014 |
20140220141 | COMPOSITIONS OF LOPINAVIR AND RITONAVIR - The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drugs lopinavir and ritonavir. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV). | 08-07-2014 |
20140220140 | COMPOSITIONS OF EFAVIRENZ - The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV). | 08-07-2014 |
20140212501 | COMPOSITIONS OF LOPINAVIR - The present invention relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug lopinavir. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV). | 07-31-2014 |
20140051659 | Oligosaccharide Compounds - The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit β-secretase. | 02-20-2014 |
20140024811 | CANCER DETECTION - Provided are methods of detecting cancer or pre-cancerous conditions in patients comprising assaying a patient sample for an elevated level of target molecules representative of expression of nucleosome assembly protein 1-like 1 (NAP1L1), wherein elevated levels of expression of NAP1L1 are indicative of a cancer of the colon, or a precancerous condition of the colon. Also provided are similar methods using panels of biomarkers such as HMGB1; PHB; RPL6; NAP1L1 and CK18. The invention also provides a method for assessing effectiveness of a therapy or putative therapy, methods of staging cancer and assessing progression of a cancer and methods of determining an appropriate cancer treatment regimen. | 01-23-2014 |
20130337369 | MIXED METAL OXIDE - The present invention relates to a mixed metal oxide exhibiting perovskite-type structural characteristics in which there are cations of Ba, Ca or Sr, a rare earth metal and Fe, Cr, Cu, Co or Mn present in three different coordination sites or a composition thereof, to a cathode composed of the mixed metal oxide or composition thereof and to a solid oxide fuel cell comprising the cathode. | 12-19-2013 |
20130268085 | SURFACE MODIFIED UNIT CELL LATTICE STRUCTURES FOR OPTIMIZED SECURE FREEFORM FABRICATION - Aspects of the present disclosure relate generally to preparing models of three-dimensional structures. In particular, a model of a three-dimensional structure constructed of porous geometries is prepared. A component file including a porous CAD volume having a boundary is prepared. A space including the porous CAD volume is populated with unit cells. The unit cells are populated with porous geometries having a plurality of struts having nodes on each end. The space is populated with at least one elongated fixation element extending beyond the boundary to produce an interlocking feature enabling assembly or engagement with a mating structure. | 10-10-2013 |
20130231450 | POLYMER-DENDRIMER HYBRIDS - The present invention relates to a branched vinyl polymer carrying dendrons made from monofunctional vinyl monomers and branched by virtue of difunctional vinyl monomers so that there is on average one branch or fewer per polymer chain to avoid gelation. The polymer may be made by chain-growth polymerization of predominantly monofunctional vinyl monomers in the presence of difunctional vinyl monomers and dendron units. | 09-05-2013 |
20120148983 | DENTAL IMPLANT - The present invention relates to a dental implant and to a process for fabricating the dental implant. | 06-14-2012 |
20120135331 | CATHODE - The present invention relates to a cathode composed of a perovskite-type or fluorite-type mixed metal oxide containing molybdenum, to a composite comprising the mixed metal oxide and to a solid oxide fuel cell comprising the cathode. The cathode mixed metal oxide has an empirical formula unit: EaTbMocOn wherein: T is one or more transition metal elements other than Mo; E is one or more metal elements selected from the group consisting of lanthanide metal elements, alkali metal elements, alkaline earth metal elements, Pb and Bi; and a, b, c, and n are non-zero numerals which may be the same or different for each element. | 05-31-2012 |
20120107832 | METHOD FOR THE DETECTION OF ORGAN OR TISSUE INJURY - This invention relates to methodology for detecting, assessing and/or diagnosing the presence of organ or tissue injury. More specifically, the present invention relates to methodology for detecting particular serum biomarkers that can be used in the detection, assessment and/or diagnosis of organ (e.g. liver) or tissue (e.g. skin) injury. | 05-03-2012 |
20120091541 | MIXED METAL OXIDES - The present invention relates to a mixed metal oxide of formula SrM1-xTixO3 wherein x is 0>x>1 and M is Hf or Zr, such as a strontium-hafnium-titanium oxide orstrontium-zirconium-titanium oxide, and to a functional device comprising the mixed metal oxide. | 04-19-2012 |
20110052586 | ANTIBODIES TO AN EPITOPE OF AGR2, ASSAYS AND HYBRIDOMAS - Provided is a monoclonal antibody, or an antigen binding fragment thereof, which binds specifically to an epitope within the sequence KPGAKKDTKDSRPKL (Sequence ID No. 2) of AGR2. Such monoclonal antibodies are of prognostic and diagnostic utility in the investigation of cancer, particularly metastatic cancer. The antibodies described may also be used in prognosis or diagnosis of inflammatory diseases. Also provided are kits and solid supports comprising such antibodies, as well as the therapeutic use of antibodies of the invention. | 03-03-2011 |
20100224489 | Electrochemical Cell - The present invention relates to an electrochemical cell comprising a vibratile electrode (eg a vibratile microelectrode). | 09-09-2010 |
20090082988 | NON-ORTHOGONAL MONITORING OF COMPLEX SYSTEMS - Apparatus for non-orthogonal monitoring of a variable measurand in a system or process, comprising: means defining at least three sources having limited spectral widths and non-orthogonal spectral outputs; a modulator means which is adapted to modulate the outputs of said sources in response to said variable measurand; at least three detectors which have non-orthogonal responsivities in the measurement domain and which receive the modulated outputs of said sources; and a processor which converts the detector outputs algorithmically into primary chromatic parameters. | 03-26-2009 |
20090010888 | Use of cytochrome P450 reductase as insecticidal target - The invention provides a method of enhancing the effectiveness of pesticides, as well as pesticidal formulations. Furthermore, it also provides the means for the de novo rational design of pesticides. The present invention also relates to a method of screening agents for potential use in insecticides, particularly against mosquitoes. | 01-08-2009 |